Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

146 questions · 165 findings · 22 reviews

No studies found 1 · 0.6%GRADE not reported 138 · 83.6%Very low 8 · 4.8%Low 11 · 6.7%Moderate 6 · 3.6%High 1 · 0.6%

Vitamin D vs placebo or control

Serum fasting triglyceride (TG, mmol/L) · Adults (general population)

Meta-analysis of randomised trials of vitamin D supplementation for Triglycerides: WMD -1.92 (95% CI -7.72 to 3.88), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.

1 finding from 1 review

Vitamin D vs placebo or control

High density lipoprotein · Adults (general population)

Meta-analysis of randomised trials of vitamin D supplementation for High density lipoprotein: WMD -0.14 (95% CI -0.99 to 0.71), not statistically significant. Umbrella review outcome-level evidence grade: Substantial effect unlikely.

1 finding from 1 review

Vitamin D vs placebo or control

Falls · Older or community-dwelling adults

Meta-analysis of randomised trials of vitamin D supplementation for Falls, Older adults: OR 0.97 (95% CI 0.84 to 1.11), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.

3 findings from 1 review

Vitamin D compounds (supplementation) vs placebo or control

Alkaline phosphatase · Adults with chronic kidney disease requiring dialysis

Meta-analysis of randomised trials of vitamin D supplementation for Alkaline phosphatase: WMD -27.35 (95% CI -50.69 to -4.01), statistically significant. Umbrella review outcome-level evidence grade: Suggestive.

1 finding from 1 review

Vitamin D vs placebo or control

Fracture · Older or community-dwelling adults

Meta-analysis of randomised trials of vitamin D supplementation for Fractures, Men aged >65 years and postmenopausal women: RR 1.01 (95% CI 0.93 to 1.09), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.

1 finding from 1 review

Vitamin D vs placebo or control

Bone mineral density in forearm · Older or community-dwelling adults

Meta-analysis of randomised trials of vitamin D supplementation for Bone mineral density in forearm, Community-dwelling adults: WMD -0.70 (95% CI -1.70 to 0.40), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.

1 finding from 1 review

Vitamin D vs placebo or control

Hip/femoral bone mineral density (BMD) · Older or community-dwelling adults

Meta-analysis of randomised trials of vitamin D supplementation for Bone mineral density in hip, Community-dwelling adults: WMD 0.70 (95% CI -0.10 to 1.60), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.

1 finding from 1 review

Vitamin D compounds (supplementation) vs placebo or control

Parathyroidectomy · Adults with chronic kidney disease requiring dialysis

Meta-analysis of randomised trials of vitamin D supplementation for Parathyroidectomy: RR 0.82 (95% CI 0.05 to 12.47), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.

1 finding from 1 review

Vitamin D vs placebo or control

Serum low‐density lipoprotein (LDL, mmol/L) · Adults (general population)

Meta-analysis of randomised trials of vitamin D supplementation for Low density lipoprotein: WMD 3.23 (95% CI 0.55 to 5.9), statistically significant. Umbrella review outcome-level evidence grade: Suggestive.

1 finding from 1 review

Vitamin D vs placebo or control

Lumbar spine bone mineral density (BMD) · children

Meta-analysis of randomised trials of vitamin D supplementation for Bone mineral density in lumbar spine, Healthy children: SMD 0.15 (95% CI -0.01 to 0.31), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.

1 finding from 1 review

Vitamin D vs placebo or control

Hip Fracture · Older or community-dwelling adults

Meta-analysis of randomised trials of vitamin D supplementation for Fractures: hip, Men aged >65 years and postmenopausal women: RR 1.15 (95% CI 0.99 to 1.33), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.

1 finding from 1 review

Vitamin D compounds (supplementation) vs placebo or control

Alkaline phosphatase · Adults with chronic kidney disease not requiring dialysis

Meta-analysis of randomised trials of vitamin D supplementation for Alkaline phosphatase: WMD -21.81 (95% CI -40.39 to 3.22), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.

1 finding from 1 review

Vitamin D vs placebo or control

Systolic blood pressure · Adults (general population)

Meta-analysis of randomised trials of vitamin D supplementation for Systolic blood pressure: WMD -2.39 (95% CI -5.7 to 0.9), not statistically significant. Umbrella review outcome-level evidence grade: Suggestive.

1 finding from 1 review

Vitamin D compounds (supplementation) vs placebo or control

Risk of hyperphosphataemia · Adults with chronic kidney disease not requiring dialysis

Meta-analysis of randomised trials of vitamin D supplementation for Risk of hyperphosphataemia: RR 1.58 (95% CI 0.47 to 5.30), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.

1 finding from 1 review

Vitamin D vs placebo or control

Maternal vitamin D concentration at term (25‐hydroxyvitamin D) (nmol/L) (ALL) · pregnant women

Meta-analysis of randomised trials of vitamin D supplementation for Maternal vitamin D concentrations at term: WMD 47.08 (95% CI 23.76 to 70.39), statistically significant. Umbrella review outcome-level evidence grade: Probable.

1 finding from 1 review

Vitamin D vs placebo or control

Bone mineral density · children

Meta-analysis of randomised trials of vitamin D supplementation for Bone mineral density (Whole body / total), Healthy children: SMD 0.1 (95% CI -0.06 to 0.26), not statistically significant. Umbrella review outcome-level evidence grade: Substantial effect unlikely.

1 finding from 1 review